Comments on the American Pharmaceutical Association on proposed rulemakings.
D004345:Drug Industry; D007883:Legislation, Medical; D008484:Medicaid; D011306:Prescription Fees; D011634:Public Health; D012957:Societies, Pharmaceutical; D014481:United States